Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery

Medical Xpress

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026. ...

전문 보기

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

AI tool can identify biological profiles associated with thrombosis risk

Engineers discover 'unexpected motion' in drug-delivery robots

Medical Xpress의 다른 기사

Natural regulator may slow several cancers by shutting down fibroblasts, study finds

Longer persistence seen with Upadacitinib versus tumor necrosis factor inhibitors in rheumatoid arthritis

Full-fat dairy shows benefits without raising body fat or cholesterol, study finds